Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Avenir Wellness Solutions Inc AVRW

Healthcare
Avenir Wellness Solutions, Inc. is a platform technology company. The Company develops proprietary wellness, nutraceutical, and topical delivery systems. The Company is focused on the development of nutraceutical formulation and delivery technologies in novel dosage forms to improve wellness. Its wholly owned subsidiary, The Sera Labs, Inc. (Sera Labs), is engaged the development, production... see more

Recent & Breaking News (OTCQB:AVRW)

CURE Pharmaceutical Completes $20 Million Acquisition of Sera Labs, a Leading Health, Wellness and Beauty Brand Marketing and Multi-Channel Distribution Platform Company

Business Wire September 24, 2020

CURE Pharmaceutical to Present at Two Virtual Events in September

GlobeNewswire September 2, 2020

LD Micro 360 Companies Set to Present this Week

Accesswire August 31, 2020

MicroCap Review Magazine Summer 2020 Issue Now Available

Accesswire August 11, 2020

CURE Pharmaceutical to Acquire Sera Labs, a Leader in the CBD Industry with Proprietary Products and Multi-Channel Distribution Platform, in a $20 Million Transaction

GlobeNewswire July 28, 2020

CURE Pharmaceutical CBD Oral Thin Film Pharmacokinetic Study Shows Improved Bioavailability Compared to CBD Soft Gel

GlobeNewswire July 15, 2020

CURE Pharmaceutical Receives NSF's cGMP Certification for Dietary Supplements

GlobeNewswire July 8, 2020

CURE Pharmaceutical Appoints Chief Business Officer

GlobeNewswire June 16, 2020

CURE Pharmaceutical Announces Exercise of Warrants for Cash Proceeds of Approximately $1.4 Million and Completes Earn Out Related to 2019 Acquisition

GlobeNewswire June 9, 2020

CURE Pharmaceutical [OTCQB:CURR] Expands to Mexico in Collaboration with Factoria Bogar Subsidiary

GlobeNewswire June 3, 2020

CURE Pharmaceutical [OTCQB:CURR] Expands Cannabis Extraction Patents, Adding Support for CBG for Therapeutic Solutions

GlobeNewswire April 21, 2020

CURE Pharmaceutical [OTCQB:CURR] Secures Chinese Patent on its Oral Thin Films to Treat Erectile Dysfunction

GlobeNewswire March 17, 2020

CURE Pharmaceutical [OTCQB:CURR] Licenses Cannabis Extraction Patents to Vanguard Scientific

GlobeNewswire February 12, 2020

UPDATE - CURE Pharmaceutical [OTCQB:CURR] Expands to Europe, Signs Licensing Agreement with ReLeaf Europe to Provide Advanced Cannabinoid Delivery

GlobeNewswire February 5, 2020

CURE Pharmaceutical [OTCQB:CURR] Expands to Europe, Signs Licensing Agreement with ReLeaf Europe to Provide Advanced Cannabinoid Delivery

GlobeNewswire February 5, 2020

CURE Pharmaceutical [OTCQB:CURR] to Present at the 12th Annual LD Micro Main Event Investor Conference

GlobeNewswire December 5, 2019

CURE Pharmaceutical [OTC: CURR] Names Canopy Rivers' Chairman, John K. Bell, To Board of Directors

GlobeNewswire November 19, 2019

CURE Pharmaceutical [OTCQB:CURR] Takes First Step to Acquire Coeptis Pharmaceuticals and its Combination Drug for Osteoarthritis Pain and Hypertension

GlobeNewswire November 14, 2019

CURE Pharmaceutical [OTCQB:CURR] Debuts CUREform Drug Delivery Line Adding Chewables and Emulsions

GlobeNewswire October 9, 2019

CURE Pharmaceutical Promotes Dr. Vered Gigi to Chief Scientific Officer

GlobeNewswire October 1, 2019